1 - 25 of 8
Number of results to display per page
TitleCreatorDate
1 Sharp Edge Eye Syndrome: A Case Report and Survey of Self-Identified IndividualsMerrick S. Reynolds; Bradley J. Katz; Kathleen B. Digre, Ben J. Brintz; Lenora M. Olson; Judith E. A. Warner2022-12
2 The Impact of Leber Hereditary Optic Neuropathy on the Quality of Life of Patients and Their Relatives: A Qualitative StudyBenson S. Chen, Erik Holzinger, Magali Taiel, Patrick Yu-Wai-Man2022-09
3 Expert Consensus on the Use of Teprotumumab for the Management of Thyroid Eye Disease Using a Modified-Delphi ApproachRaymond S. Douglas, Andrea L. Kossler, Jody Abrams, Cesar A. Briceño, David Gay, Andrew Harrison, Michael Lee, John Nguyen, Shannon S. Joseph, Dianne Schlachter, Jeremy Tan, Judah Lynch, Louisa Oliver, Richard Perry, Shoaib Ugradar2022-09
4 Impact of Greater Occipital Nerve Block on Photophobia Levels in Migraine PatientsJavier A Membrilla, Íñigo de Lorenzo, Lucía Sánchez-Casado, María Sastre, Javier Díaz de Terán2022-09
5 Rehabilitation of Visual Loss: Where We Are and Where We Need to BeBehzad Mansouri, MD, PhD, FRCPC, Marinya Roznik, BSc, Joseph F. Rizzo III, MD,Sashank Prasad, MD2018-06
6 More Than Meets the Eye: The Eye and Migraine -- What You Need to KnowKathleen B. Digre, MD2018-06
7 Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment TrialMartin W. ten Hove, MD, Deborah I. Friedman, MD, Anil D. Patel, MD, Isabella Irrcher, PhD, Michael Wall, MD, Michael P. McDermott, PhD, for the NORDIC Idiopathic Intracranial Hypertension Study Group2016-03
8 Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment TrialKimberly E. Cello, BS, John L. Keltner, MD, Chris A. Johnson, PhD, Michael Wall, MD for the NORDIC Idiopathic Intracranial Hypertension Study Group2016-03
1 - 25 of 8